News related to Stalevo (Carbidopa / Levodopa / Entacapone) and/or conditions it is approved for
Schering Plough Reports Preladenant Meets Primary Endpoint In Phase II Dose-Finding Trial For Parkinson's Disease
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.28]
Schering-Plough Corporation (NYSE: SGP) reported that preladenant, its novel and selective adenosine2a receptor antagonist, met the primary endpoint in a Phase II dose-finding trial in patients suffering from moderate to severe Parkinson's disease experiencing motor fluctuations and abnormal involuntary movements (dyskinesias). The trial results were presented at the company's 2008 R&D Update meeting being hosted for analysts and portfolio managers at company headquarters.
Ceregene Announces Clinical Data From Phase 2 Clinical Trial Of CERE-120 For Parkinson's Disease
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.27]
Ceregene, Inc., a biopharmaceutical company, reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease. The trial did not demonstrate an appreciable difference between patients treated with CERE-120 versus those in the control group.
Researchers Define Ideal Time For Stem Cell Collection For Parkinson's Disease Therapy
Source: Conferences News From Medical News Today [2008.11.20]
Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience. Lorraine Iacovitti, Ph.D.
Stem Cell Collection For Parkinson's Disease Therapy: Jefferson Researchers Define Ideal Time
Source: Stem Cell Research News From Medical News Today [2008.11.20]
Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience. Lorraine Iacovitti, Ph.D.
Gout May Protect Against Risk of Parkinson's Disease
Source: MedPage Today Rheumatology [2008.11.07]
VANCOUVER, British Columbia (MedPage Today) -- Patients with gout were less likely to develop Parkinson's disease, a cohort study found, supporting the purported protective role of uric acid.
Parkinson's Disease
Source: MedicineNet levodopa-carbidopa Specialty [2005.12.17]
Title: Parkinson's Disease
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/17/2005
Transdermal Rotigotine Patch Safe, Effective in Early Idiopathic Parkinson's Disease
Source: Medscape Pharmacotherapy Headlines [2004.06.17]
Delivery system may help avoid oral therapy?s abrupt 'off' state.
Medscape Medical News
Paula Moyer
A Model System To Elucidate The Origin Of Protein Misfolding Neurodegenerative Diseases
Source: Muscular Dystrophy / ALS News From Medical News Today [2008.11.28]
Amyotropic lateral sclerosis (ALS) is a neurodegenerative disease linked to the misfolding and aggregation of the dimers of the enzyme superoxide dismutase (SOD1). Other neurodegenerative disorders like Alzheimer's disease, Creutzfeld-Jakob disease and Parkinson's disease are also associated with protein misfolding and aggregation.
More Than 100 Scientific Abstracts Presented By GU/GUMC Researchers At Neuroscience 2008
Source: Autism News From Medical News Today [2008.11.20]
Research highlights include how we see faces in our dreams, understanding how young and old adults learn, helping stroke survivors speak using fMRI, an explanation about autism and facial recognition and ways to possibly forestall Parkinson's disease.
Royal Assent For Human Fertilisation And Embryology Act
Source: Fertility News From Medical News Today [2008.11.14]
New laws that will help maintain the UK's position as a world leader in embryo research, enable scientists to investigate cures for serious illnesses such as Parkinson's disease and regulate assisted reproductive treatments, received Royal Assent today. The new Human Fertilisation and Embryology Act updates the 1990 law to ensure that it is fit for purpose in the 21st Century and keeps the UK at the forefront of developments in treatment and research.
Treatment For Gout And The Condition's Protective Effects
Source: Gout News From Medical News Today [2008.11.05]
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease. At the same time, high serum urate levels have been shown to lower the risk of developing Parkinson's disease (PD). A new study compared the safety and efficacy of febuxostat, a new drug being developed for gout that was recently approved for use in Europe, and a commonly used drug that has been around for years.
Additional Pain In Parkinson's Patients Due To Involuntary Muscle Contractions
Source: Body Aches News From Medical News Today [2008.09.09]
Italian researchers suggest that pain is associated with Parkinson's disease after finding that pain appears more common in people who suffer from the condition than in those who do not. Their results are published in the September issue of Archives of Neurology. "Patients with Parkinson's disease often complain of painful sensations that may involve body parts affected and unaffected by dystonia [involuntary muscle contractions]," write author Giovanni Defazio, M.
|
